4 insider filings
Lindsay Androski, insider filing for ABUS
Show all 4
- 4Insider filing for ABUS
- 4Insider filing for ABUS
- 4Insider filing for ABUS
- 4Insider filing for ABUS
Lindsay Androski, reporting
ABUS
Arbutus Biopharma Corp SEC filings
Every EDGAR filing for Arbutus Biopharma Corp (ABUS), newest first, with AI summaries and stories.
- Ticker
- ABUS
- CIK
- 1447028
- Latest filing
- Oct 8
Next: earnings expected ~Nov 9 ยท 10-Q expected ~Nov 10 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 12 grants or exercises.
Filings
4Arbutus Biopharma CorpABUSLIVE SCHEDULE 13G/AArbutus Biopharma CorpABUSLIVE Arbutus Biopharma Corp shares held by Morgan Stanley
- Morgan Stanley holds 12.2% of Arbutus Biopharma Corp shares
- Morgan Stanley Investment Management Inc. holds 11.3% of Arbutus Biopharma Corp shares
- Total shares beneficially owned by Morgan Stanley: 18,682,708
Stanley Morgan, filed by
SCHEDULE 13D/AArbutus Biopharma CorpABUSLIVE Arbutus Biopharma Corp shares held by Roivant
- Roivant owns 29,880,079 shares
- 19.5% of outstanding shares
- Tender offer completed on Sep 29, 2026
Roivant Sciences Ltd.
4Arbutus Biopharma CorpABUSLIVE Arbutus Biopharma Corp reports ownership change
- Roivant Sciences Ltd. disposed of 8,967,383 common shares
- Transaction date: 10/01/2026
- Shares beneficially owned: 29,880,079
Roivant Sciences Ltd.
SC TO-I/AArbutus Biopharma CorpABUSLIVE SC TO-I/AArbutus Biopharma CorpABUSLIVE 4Arbutus Biopharma CorpABUSLIVE 4 insider filings
Lindsay Androski, insider filing for ABUS
Show all 4
- 4Insider filing for ABUS
- 4Insider filing for ABUS
- 4Insider filing for ABUS
- 4Insider filing for ABUS
Lindsay Androski, reporting
SCHEDULE 13GArbutus Biopharma CorpABUSLIVE Ownership stake disclosure by Whitefort Capital Management, LP
Whitefort Capital Management, LP, filed by
SC TO-IArbutus Biopharma CorpABUSLIVE SC TO-CArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE 10-QArbutus Biopharma CorpABUSLIVE SCHEDULE 13G/AArbutus Biopharma CorpABUSLIVE Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
8-KArbutus Biopharma CorpABUSLIVE 4Arbutus Biopharma CorpABUSLIVE 2 insider filings
Roger Sawhney, insider filing for ABUS
Show all 2
- 4Insider filing for ABUS
- 4Insider filing for ABUS
Roger Sawhney, reporting
S-8Arbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE SCHEDULE 13G/AArbutus Biopharma CorpABUSLIVE Ownership stake disclosure by Two Seas Capital LP (amended)
Two Seas Capital LP, filed by
10-QArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE SCHEDULE 13D/AArbutus Biopharma CorpABUSLIVE Ownership stake disclosure by Whitefort Capital Management, LP (amended)
Whitefort Capital Management, LP, filed by
8-KArbutus Biopharma CorpABUSLIVE DEFA14AArbutus Biopharma CorpABUSLIVE DEF 14AArbutus Biopharma CorpABUSLIVE SCHEDULE 13D/AArbutus Biopharma CorpABUSLIVE Ownership stake disclosure by Whitefort Capital Management, LP (amended)
Whitefort Capital Management, LP, filed by
10-KArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE SCHEDULE 13G/AArbutus Biopharma CorpABUSLIVE Ownership stake disclosure by Two Seas Capital LP (amended)
Two Seas Capital LP, filed by
SCHEDULE 13G/AArbutus Biopharma CorpABUSLIVE Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
8-KArbutus Biopharma CorpABUSLIVE 4Arbutus Biopharma CorpABUSLIVE 2 insider filings
Tuan Nguyen, insider filing for ABUS
Show all 2
- 4Insider filing for ABUS
- 4Insider filing for ABUS
Tuan Nguyen, reporting
8-KArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE 8-KArbutus Biopharma CorpABUSLIVE 10-QArbutus Biopharma CorpABUSLIVE